BOSTON, February 7, 2019- H.I.G. Capital ("H.I.G. "), a leading global private equity investment firm with $30 billion of equity capital under management*, is pleased to announce that one of its affiliates has partnered with the management team of Taconic Biosciences, Inc., (“Taconic” or the “Company”) to support the Company’s growth as a leading global provider of research models and services to the pharmaceutical, biotechnology, CRO, and academic research industries.